Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Asia Pacific is the most rapidly expanding region in the GLP-1 Receptor Agonist Market, owing to Japan's high rate of GLP-1 prescription, strong diabetes pharmacotherapy background, China's large number of diabetic patients, and rapid growth in the Indian pharmaceutical industry
Subcutaneous injection is the only route with published pharmacokinetic data (rodent studies), making it the better-characterized delivery method
P.MazumdarA.MayerJ
The particle sizes are carefully controlled between 50 and 150nm to ensure the best uptake by cells
This trial, ATTAIN-2, was a double-blind 72-week trial in 136 sites across 10 countries
US$ 23.89
US$ 22.25
US$ 23.06
US$ 22.01
US$ 20.04
US$ 27.74
US$ 20.12
US$ 21.48
US$ 24.39
US$ 27.90
